Drug labelling problems ironed out by new catalyst

US researchers have developed a new one-step procedure for introducing tritium radiolabels into pharmaceuticals in unique molecular positions by using an iron catalyst. The method not only provides a new diagnostic tool for ADMA (absorption, distribution, metabolism, excretion) studies, which are essential to assay the efficacy and safety of drug like compounds, but also minimises radioactive waste. Read more.

Tags: PET Research

About NMC  |  Products  |  Quote  |  News  |  Resources  |  Contact  |  Sitemap